Amplifon SpA
MIL:AMP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.8
26.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IT |
|
Amplifon SpA
MIL:AMP
|
3.1B EUR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
100.9B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
67.8B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49.6B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.2B AUD |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
66.1B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.2B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.8B CNY |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD |
Loading...
|
Market Distribution
| Min | -79 476% |
| 30th Percentile | 3.9% |
| Median | 8.7% |
| 70th Percentile | 14.4% |
| Max | 813.7% |
Other Profitability Ratios
Amplifon SpA
Glance View
Amplifon SpA, a global leader in hearing solutions, crafts its story around a mission to enhance auditory experiences for individuals worldwide. The company, founded in 1950 by Algernon Charles Holland in Milan, Italy, began as a modest venture but evolved into a dominant force in the audiology market. Amplifon operates through an extensive network of clinics and service centers, boasting a widespread presence across Europe, the Americas, Asia-Pacific, and Africa. Each location serves as a hub where highly trained audiologists and specialists offer personalized hearing assessments and consultations. This localized approach allows the company to cater uniquely to each customer's needs, delivering tailored solutions such as hearing aids, devices, and accessories from leading brands, as well as a suite of supportive services. The company's business model effectively harnesses a comprehensive and vertically integrated structure. Amplifon generates revenue by not just selling hearing devices, but also by providing related services like fittings, aftercare, and support. This approach creates a recurring income stream, as customers often require ongoing maintenance and upgrades to their devices. Additionally, Amplifon invests heavily in research and development, ensuring its offerings incorporate the latest technological advancements. By focusing on innovation and customer satisfaction, Amplifon maintains strong relationships with both its suppliers and clientele, fortifying its position in the competitive landscape of hearing solutions. Through a combination of strategy, service, and an unwavering commitment to quality, the company continues to expand its influence and drive growth in the global market.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Amplifon SpA is 9.6%, which is below its 3-year median of 11.9%.
Over the last 3 years, Amplifon SpA’s Operating Margin has decreased from 13.8% to 9.6%. During this period, it reached a low of 9.6% on Sep 30, 2025 and a high of 13.8% on Sep 30, 2022.